U.S. Basic Materials Stock News

Why Expand Energy Is On Investors’ Radar Expand Energy (EXE) has been drawing attention after its recent rebrand from Chesapeake Energy Corporation, shifting the focus to its natural gas production footprint across key US shale plays. See our latest analysis for Expand Energy. Since the rebrand, the share price has eased back, with a 1 month share price return of a 14.19% decline and a year to date share price return of a 3.95% decline. However, the 3 year total shareholder return of 32.41%...

Hamilton Insurance Group (NYSE:HG) has drawn attention after recent share price moves, with the stock down 2.1% on the day and 4.1% over the past week, while remaining modestly positive over the past month. See our latest analysis for Hamilton Insurance Group. Zooming out, the recent 1 day and 7 day share price declines sit against an 8.5% 90 day share price return and a 41.8% 1 year total shareholder return. This suggests momentum has cooled in the short term but remains supportive over a...

Event overview and why it matters Centuri Holdings (CTRI) recently reported more than $870 million in new bookings across North America, mostly from renewed long term agreements with utility customers and additional work tied to energy infrastructure projects. See our latest analysis for Centuri Holdings. The recent $870 million in bookings comes as Centuri Holdings’ share price has climbed to $27.11, with a 90 day share price return of 33.35% and a 1 year total shareholder return of 35.14%...

If you are trying to figure out whether Roblox shares are priced attractively today, the starting point is understanding what the current market price is actually implying about the business. Roblox closed at US$75.83, with returns of a 7.3% decline over the last week, a 21.2% decline over the last month, a 6.3% decline year to date, a 23.7% gain over the last year and a 3 year return of around 1.4x. Recent coverage has focused on Roblox as a major player in user generated gaming platforms...

Ardagh Metal Packaging recently reported higher revenue and profit than a year earlier and outlined steps to strengthen its balance sheet by extending debt maturities and improving investor disclosure. This combination of better earnings and clearer communication comes despite ongoing industry headwinds, including mixed packaging demand and concerns over the company’s high debt load and North American market-share risk. Next, we’ll examine how stronger recent results and Ardagh’s efforts to...

Reports from CES 2026 that LG and Samsung launched audio products aimed at Sonos (SONO) helped push the stock down, as investors were already cautious about projections for the upcoming quarter. See our latest analysis for Sonos. Those CES headlines and cautious quarterly projections come after a strong 12 months for Sonos, with a 1 year total shareholder return of 14.44%, even as recent 30 day and 90 day share price returns of 11.02% and 5.54% declines suggest momentum has started to fade...

AeroVironment recently secured U.S. Army contracts worth about US$887 million for unmanned aircraft and counter-drone systems, adding to a multi-year order pipeline supported by the BlueHalo acquisition and a growing backlog of US$1.40 billion in new bookings. These long-duration defense awards enhance revenue visibility through 2031 and have coincided with heightened institutional interest and unusually active, mostly bullish options trading in the stock. Now, we'll assess how this large,...

Positive Phase 3 results for Ziihera in HER2 positive first line metastatic gastroesophageal adenocarcinoma have put Zymeworks (ZYME) back in focus, as investors weigh potential milestone payments tied to future regulatory decisions. See our latest analysis for Zymeworks. The latest Ziihera update lands after a sharp 44.96% 90 day share price return and a 68.97% total shareholder return over the past year. However, shorter term share price returns have recently cooled, suggesting momentum has...

NXP Semiconductors and GE HealthCare recently announced a collaboration to showcase new edge AI concepts for anesthesia and neonatal monitoring at CES 2026, using NXP processors and GE HealthCare’s Responsible AI framework. The partnership highlights how local, low-latency AI processing at the bedside could change how clinicians interact with equipment and monitor vulnerable patients. Next, we’ll explore how this push into edge AI for anesthesia and neonatal care may influence GE...

Apollo Global Management recently led a US$1.20 billion convertible perpetual preferred equity financing for QXO, Inc., providing capital to pursue acquisition opportunities through mid-2026 and potentially beyond. This transaction highlights Apollo’s role as a key capital provider in large, acquisition-focused financings, reinforcing its presence in complex private-market deal structures. We’ll now examine how Apollo’s lead role in QXO’s US$1.20 billion financing might influence its broader...

Hydrogen megaprojects put Air Products and Chemicals (APD) in focus Recent hydrogen megaproject announcements, including Air Products and Chemicals (APD) work on the Louisiana Clean Energy Complex and Saudi Arabia’s NEOM Green Hydrogen Project, have put the stock back on many investors’ radar. See our latest analysis for Air Products and Chemicals. Those hydrogen announcements have arrived during a mixed period for investors, with the share price at $258.36 and a year to date share price...

In 2025, GoDaddy stepped up its AI push with products like Airo.ai and enhanced WordPress tools, while also approving a US$900 million share repurchase program following solid but slightly below-expectation earnings and cautious guidance. This combination of heavy AI investment and large buybacks highlights management’s confidence in the business model even as some investors question the earnings outlook. Next, we’ll examine how GoDaddy’s sizable new share repurchase plan reshapes the...

Teradata stock: recent performance snapshot Teradata (TDC) has quietly posted a 4.1% gain over the past month and a 40.2% move in the past 3 months, drawing fresh attention to its US$31.09 share price and underlying fundamentals. See our latest analysis for Teradata. That recent 40.2% 3 month share price return comes after a much flatter picture over longer periods, with a 1 year total shareholder return of 0.6% decline and a 3 year total shareholder return of 5.8% decline. This suggests...

Evercore ISI Group recently upgraded iRhythm Technologies (IRTC) to an Outperform rating, a shift that has drawn fresh attention to the stock and its potential role in cardiac monitoring exposure. See our latest analysis for iRhythm Technologies. The Evercore ISI upgrade comes after a period where iRhythm’s share price has been relatively steady in the shorter term, with a 30 day share price return of 3.71%, while the 1 year total shareholder return of 104.24% points to strong momentum that...

Sterling Infrastructure (STRL) is back in focus after its E-Infrastructure Solutions segment reported 125% year-over-year data center revenue growth in Q3 2025 and closed the CEC acquisition, which expanded its electrical capabilities. See our latest analysis for Sterling Infrastructure. Those data center gains and the CEC deal come as the share price has eased in the short term, with a 90 day share price return showing a 13.51% decline, while the 1 year total shareholder return of 89.40% and...

On 6 January 2026, TPG Inc. and Jackson Financial Inc. announced a long‑term investment management partnership under which TPG will manage at least US$12.00 billion of Jackson assets, targeting US$20.00 billion, alongside a US$500.00 million minority equity investment in Jackson and US$150.00 million of TPG stock issued to Jackson. The cross‑equity structure and large credit mandate deepen TPG’s insurance footprint, reinforcing its push into asset‑light fee income from investment‑grade...

In late 2025, Intellia Therapeutics paused dosing and enrollment in its late-stage MAGNITUDE trials for nexiguran ziclumeran after a patient death from severe liver-related side effects led the FDA to place the program on clinical hold, prompting the company to suspend milestone guidance while it works with regulators on a path forward. This setback directly affects Intellia’s leading in vivo CRISPR program and raises fresh questions about liver safety risks across its broader gene-editing...

In its most recent reported quarter, Mercury Systems posted year-over-year revenue growth of 10.2%, with backlog, adjusted EBITDA, and free cash flow all improving and results coming in ahead of analyst expectations. The company also achieved the biggest analyst estimates beat among defense contractors, helped by accelerated deliveries on several high-priority customer programs, highlighting the impact of execution on its financial performance. Next, we’ll explore how this strong estimates...

Amprius Technologies (AMPX) is back on investor radars after receiving a CES 2026 Innovation Award for its 520 Wh/kg silicon anode battery and showcasing a Nokia drone powered by its high energy density cells. See our latest analysis for Amprius Technologies. Those CES 2026 headlines arrive after a mixed stretch for the stock, with a 7 day share price return of 17.37% following a 30 day share price decline of 24.55%. The 1 year total shareholder return of 159.60% points to strong longer term...

Why the new ETFs and fusion talks matter for DJT Trump Media & Technology Group (DJT) has moved beyond social media headlines with two attention grabbing steps: launching five America first themed Truth Social ETFs and entering discussions around potential fusion power plant sites. For you as a shareholder or watcher of DJT, these moves raise clear questions: how much diversification they really add to a tiny revenue base, what risks they introduce, and whether the recent share price recovery...

In recent months, OSI Systems has secured new contracts for baggage and cargo inspection systems, reinforcing its security and aviation businesses and adding to its recurring revenue base and backlog. This contract momentum underpins the company’s role in multiyear upgrade programs for aviation security and critical infrastructure, which are central to its long-term business mix. We’ll now examine how these fresh security contract wins and stronger recurring revenue streams may shape OSI...

Watsco (WSO) has been drawing attention after a period of mixed share performance, with the stock showing gains over the month but a negative total return across the past 3 months and year. See our latest analysis for Watsco. At a share price of $357.19, Watsco’s recent 7 day share price return of 4.1% contrasts with a 90 day share price decline of 9.9%, while the 5 year total shareholder return of 71.3% reflects a stronger longer term picture. If Watsco’s recent moves have you reviewing your...

Enovis (ENOV) has created a new Chief Administrative Officer role and appointed former McKinsey senior partner Oliver Engert, in a leadership move aimed at sharpening strategy, efficiency and capital discipline after recent operational challenges. See our latest analysis for Enovis. At a share price of US$27.92, Enovis has seen a 3.3% 1 day and 3.3% 30 day share price return, but its 1 year total shareholder return of 37.6% and 5 year total shareholder return of 60.0% decline suggest momentum...

In recent days, Thermo Fisher Scientific drew attention as investors looked ahead to its now‑completed fourth‑quarter and full‑year 2025 results and progress on the planned multibillion‑dollar acquisition of clinical‑trial services firm Clario. The focus on upcoming earnings, organic revenue trends, and margin commentary highlighted how closely the market is tracking Thermo Fisher’s core profitability and outlook for pharma and biotech demand. With investors scrutinizing management’s margin...